ArticleVaccines2025

COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer.

Emanuele Vita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.